Global High Potency Active Pharmaceutical Ingredient Sales Market Report 2016

October 2016 | 108 pages | ID: G643B0FF566EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of High Potency Active Pharmaceutical Ingredient

Revenue, means the sales value of High Potency Active Pharmaceutical Ingredient

This report studies sales (consumption) of High Potency Active Pharmaceutical Ingredient in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

• Alkermes
• Cambex
• Dr. Reddy’s Labotatories
• Lonza Group
• Novasep
• Sandoz

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of High Potency Active Pharmaceutical Ingredient in these regions, from 2011 to 2021 (forecast), like

• United States
• China
• Europe
• Japan

Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into

• Synthetic
• Biotech
• Type III

Split by applications, this report focuses on sales, market share and growth rate of High Potency Active Pharmaceutical Ingredient in each application, can be divided into

• Oncology
• Hormonal disorders
• Glaucoma
• Others

Contents

Global High Potency Active Pharmaceutical Ingredient Sales Market Report 2016

1 HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENT OVERVIEW

1.1 Product Overview and Scope of High Potency Active Pharmaceutical Ingredient
1.2 Classification of High Potency Active Pharmaceutical Ingredient
  1.2.1 Synthetic
  1.2.2 Biotech
  1.2.3 Type III
1.3 Application of High Potency Active Pharmaceutical Ingredient
  1.3.1 Oncology
  1.3.2 Hormonal disorders
  1.3.3 Glaucoma
  1.3.4 Others
1.4 High Potency Active Pharmaceutical Ingredient Market by Regions
  1.4.1 United States Status and Prospect (2011-2021)
  1.4.2 China Status and Prospect (2011-2021)
  1.4.3 Europe Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of High Potency Active Pharmaceutical Ingredient (2011-2021)
  1.5.1 Global High Potency Active Pharmaceutical Ingredient Sales and Growth Rate (2011-2021)
  1.5.2 Global High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2021)

2 GLOBAL HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENT COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Global High Potency Active Pharmaceutical Ingredient Market Competition by Manufacturers
  2.1.1 Global High Potency Active Pharmaceutical Ingredient Sales and Market Share of Key Manufacturers (2011-2016)
  2.1.2 Global High Potency Active Pharmaceutical Ingredient Revenue and Share by Manufacturers (2011-2016)
2.2 Global High Potency Active Pharmaceutical Ingredient (Volume and Value) by Type
  2.2.1 Global High Potency Active Pharmaceutical Ingredient Sales and Market Share by Type (2011-2016)
  2.2.2 Global High Potency Active Pharmaceutical Ingredient Revenue and Market Share by Type (2011-2016)
2.3 Global High Potency Active Pharmaceutical Ingredient (Volume and Value) by Regions
  2.3.1 Global High Potency Active Pharmaceutical Ingredient Sales and Market Share by Regions (2011-2016)
  2.3.2 Global High Potency Active Pharmaceutical Ingredient Revenue and Market Share by Regions (2011-2016)
2.4 Global High Potency Active Pharmaceutical Ingredient (Volume) by Application

3 UNITED STATES HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENT (VOLUME, VALUE AND SALES PRICE)

3.1 United States High Potency Active Pharmaceutical Ingredient Sales and Value (2011-2016)
  3.1.1 United States High Potency Active Pharmaceutical Ingredient Sales and Growth Rate (2011-2016)
  3.1.2 United States High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2016)
  3.1.3 United States High Potency Active Pharmaceutical Ingredient Sales Price Trend (2011-2016)
3.2 United States High Potency Active Pharmaceutical Ingredient Sales and Market Share by Manufacturers
3.3 United States High Potency Active Pharmaceutical Ingredient Sales and Market Share by Type
3.4 United States High Potency Active Pharmaceutical Ingredient Sales and Market Share by Application

4 CHINA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENT (VOLUME, VALUE AND SALES PRICE)

4.1 China High Potency Active Pharmaceutical Ingredient Sales and Value (2011-2016)
  4.1.1 China High Potency Active Pharmaceutical Ingredient Sales and Growth Rate (2011-2016)
  4.1.2 China High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2016)
  4.1.3 China High Potency Active Pharmaceutical Ingredient Sales Price Trend (2011-2016)
4.2 China High Potency Active Pharmaceutical Ingredient Sales and Market Share by Manufacturers
4.3 China High Potency Active Pharmaceutical Ingredient Sales and Market Share by Type
4.4 China High Potency Active Pharmaceutical Ingredient Sales and Market Share by Application

5 EUROPE HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENT (VOLUME, VALUE AND SALES PRICE)

5.1 Europe High Potency Active Pharmaceutical Ingredient Sales and Value (2011-2016)
  5.1.1 Europe High Potency Active Pharmaceutical Ingredient Sales and Growth Rate (2011-2016)
  5.1.2 Europe High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2016)
  5.1.3 Europe High Potency Active Pharmaceutical Ingredient Sales Price Trend (2011-2016)
5.2 Europe High Potency Active Pharmaceutical Ingredient Sales and Market Share by Manufacturers
5.3 Europe High Potency Active Pharmaceutical Ingredient Sales and Market Share by Type
5.4 Europe High Potency Active Pharmaceutical Ingredient Sales and Market Share by Application

6 JAPAN HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENT (VOLUME, VALUE AND SALES PRICE)

6.1 Japan High Potency Active Pharmaceutical Ingredient Sales and Value (2011-2016)
  6.1.1 Japan High Potency Active Pharmaceutical Ingredient Sales and Growth Rate (2011-2016)
  6.1.2 Japan High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2016)
  6.1.3 Japan High Potency Active Pharmaceutical Ingredient Sales Price Trend (2011-2016)
6.2 Japan High Potency Active Pharmaceutical Ingredient Sales and Market Share by Manufacturers
6.3 Japan High Potency Active Pharmaceutical Ingredient Sales and Market Share by Type
6.4 Japan High Potency Active Pharmaceutical Ingredient Sales and Market Share by Application

7 GLOBAL HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENT MANUFACTURERS ANALYSIS

7.1 Alkermes
  7.1.1 Company Basic Information, Manufacturing Base and Competitors
  7.1.2 High Potency Active Pharmaceutical Ingredient Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 Alkermes High Potency Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)
  7.1.4 Main Business/Business Overview
7.2 Cambex
  7.2.1 Company Basic Information, Manufacturing Base and Competitors
  7.2.2 108 Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 Cambex High Potency Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)
  7.2.4 Main Business/Business Overview
7.3 Dr. Reddy’s Labotatories
  7.3.1 Company Basic Information, Manufacturing Base and Competitors
  7.3.2 125 Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 Dr. Reddy’s Labotatories High Potency Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)
  7.3.4 Main Business/Business Overview
7.4 Lonza Group
  7.4.1 Company Basic Information, Manufacturing Base and Competitors
  7.4.2 Oct Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 Lonza Group High Potency Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)
  7.4.4 Main Business/Business Overview
7.5 Novasep
  7.5.1 Company Basic Information, Manufacturing Base and Competitors
  7.5.2 Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 Novasep High Potency Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)
  7.5.4 Main Business/Business Overview
7.6 Sandoz
  7.6.1 Company Basic Information, Manufacturing Base and Competitors
  7.6.2 Million USD Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 Sandoz High Potency Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)
  7.6.4 Main Business/Business Overview

8 HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENT MAUFACTURING COST ANALYSIS

8.1 High Potency Active Pharmaceutical Ingredient Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Process Analysis of High Potency Active Pharmaceutical Ingredient

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 High Potency Active Pharmaceutical Ingredient Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of High Potency Active Pharmaceutical Ingredient Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENT MARKET FORECAST (2016-2021)

12.1 Global High Potency Active Pharmaceutical Ingredient Sales, Revenue Forecast (2016-2021)
12.2 Global High Potency Active Pharmaceutical Ingredient Sales Forecast by Regions (2016-2021)
12.3 Global High Potency Active Pharmaceutical Ingredient Sales Forecast by Type (2016-2021)
12.4 Global High Potency Active Pharmaceutical Ingredient Sales Forecast by Application (2016-2021)

13 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of High Potency Active Pharmaceutical Ingredient
Table Classification of High Potency Active Pharmaceutical Ingredient
Figure Global Sales Market Share of High Potency Active Pharmaceutical Ingredient by Type in 2015
Figure Synthetic Picture
Figure Biotech Picture
Table Applications of High Potency Active Pharmaceutical Ingredient
Figure Global Sales Market Share of High Potency Active Pharmaceutical Ingredient by Application in 2015
Figure Oncology Examples
Figure Hormonal disorders Examples
Figure Glaucoma Examples
Figure Others Examples
Figure United States High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2021)
Figure China High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2021)
Figure Europe High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2021)
Figure Japan High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2021)
Figure Global High Potency Active Pharmaceutical Ingredient Sales and Growth Rate (2011-2021)
Figure Global High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2021)
Table Global High Potency Active Pharmaceutical Ingredient Sales of Key Manufacturers (2011-2016)
Table Global High Potency Active Pharmaceutical Ingredient Sales Share by Manufacturers (2011-2016)
Figure 2015 High Potency Active Pharmaceutical Ingredient Sales Share by Manufacturers
Figure 2016 High Potency Active Pharmaceutical Ingredient Sales Share by Manufacturers
Table Global High Potency Active Pharmaceutical Ingredient Revenue by Manufacturers (2011-2016)
Table Global High Potency Active Pharmaceutical Ingredient Revenue Share by Manufacturers (2011-2016)
Table 2015 Global High Potency Active Pharmaceutical Ingredient Revenue Share by Manufacturers
Table 2016 Global High Potency Active Pharmaceutical Ingredient Revenue Share by Manufacturers
Table Global High Potency Active Pharmaceutical Ingredient Sales and Market Share by Type (2011-2016)
Table Global High Potency Active Pharmaceutical Ingredient Sales Share by Type (2011-2016)
Figure Sales Market Share of High Potency Active Pharmaceutical Ingredient by Type (2011-2016)
Figure Global High Potency Active Pharmaceutical Ingredient Sales Growth Rate by Type (2011-2016)
Table Global High Potency Active Pharmaceutical Ingredient Revenue and Market Share by Type (2011-2016)
Table Global High Potency Active Pharmaceutical Ingredient Revenue Share by Type (2011-2016)
Figure Revenue Market Share of High Potency Active Pharmaceutical Ingredient by Type (2011-2016)
Figure Global High Potency Active Pharmaceutical Ingredient Revenue Growth Rate by Type (2011-2016)
Table Global High Potency Active Pharmaceutical Ingredient Sales and Market Share by Regions (2011-2016)
Table Global High Potency Active Pharmaceutical Ingredient Sales Share by Regions (2011-2016)
Figure Sales Market Share of High Potency Active Pharmaceutical Ingredient by Regions (2011-2016)
Figure Global High Potency Active Pharmaceutical Ingredient Sales Growth Rate by Regions (2011-2016)
Table Global High Potency Active Pharmaceutical Ingredient Revenue and Market Share by Regions (2011-2016)
Table Global High Potency Active Pharmaceutical Ingredient Revenue Share by Regions (2011-2016)
Figure Revenue Market Share of High Potency Active Pharmaceutical Ingredient by Regions (2011-2016)
Figure Global High Potency Active Pharmaceutical Ingredient Revenue Growth Rate by Regions (2011-2016)
Table Global High Potency Active Pharmaceutical Ingredient Sales and Market Share by Application (2011-2016)
Table Global High Potency Active Pharmaceutical Ingredient Sales Share by Application (2011-2016)
Figure Sales Market Share of High Potency Active Pharmaceutical Ingredient by Application (2011-2016)
Figure Global High Potency Active Pharmaceutical Ingredient Sales Growth Rate by Application (2011-2016)
Figure United States High Potency Active Pharmaceutical Ingredient Sales and Growth Rate (2011-2016)
Figure United States High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2016)
Figure United States High Potency Active Pharmaceutical Ingredient Sales Price Trend (2011-2016)
Table United States High Potency Active Pharmaceutical Ingredient Sales by Manufacturers (2011-2016)
Table United States High Potency Active Pharmaceutical Ingredient Market Share by Manufacturers (2011-2016)
Table United States High Potency Active Pharmaceutical Ingredient Sales by Type (2011-2016)
Table United States High Potency Active Pharmaceutical Ingredient Market Share by Type (2011-2016)
Table United States High Potency Active Pharmaceutical Ingredient Sales by Application (2011-2016)
Table United States High Potency Active Pharmaceutical Ingredient Market Share by Application (2011-2016)
Figure China High Potency Active Pharmaceutical Ingredient Sales and Growth Rate (2011-2016)
Figure China High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2016)
Figure China High Potency Active Pharmaceutical Ingredient Sales Price Trend (2011-2016)
Table China High Potency Active Pharmaceutical Ingredient Sales by Manufacturers (2011-2016)
Table China High Potency Active Pharmaceutical Ingredient Market Share by Manufacturers (2011-2016)
Table China High Potency Active Pharmaceutical Ingredient Sales by Type (2011-2016)
Table China High Potency Active Pharmaceutical Ingredient Market Share by Type (2011-2016)
Table China High Potency Active Pharmaceutical Ingredient Sales by Application (2011-2016)
Table China High Potency Active Pharmaceutical Ingredient Market Share by Application (2011-2016)
Figure Europe High Potency Active Pharmaceutical Ingredient Sales and Growth Rate (2011-2016)
Figure Europe High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2016)
Figure Europe High Potency Active Pharmaceutical Ingredient Sales Price Trend (2011-2016)
Table Europe High Potency Active Pharmaceutical Ingredient Sales by Manufacturers (2011-2016)
Table Europe High Potency Active Pharmaceutical Ingredient Market Share by Manufacturers (2011-2016)
Table Europe High Potency Active Pharmaceutical Ingredient Sales by Type (2011-2016)
Table Europe High Potency Active Pharmaceutical Ingredient Market Share by Type (2011-2016)
Table Europe High Potency Active Pharmaceutical Ingredient Sales by Application (2011-2016)
Table Europe High Potency Active Pharmaceutical Ingredient Market Share by Application (2011-2016)
Figure Japan High Potency Active Pharmaceutical Ingredient Sales and Growth Rate (2011-2016)
Figure Japan High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2016)
Figure Japan High Potency Active Pharmaceutical Ingredient Sales Price Trend (2011-2016)
Table Japan High Potency Active Pharmaceutical Ingredient Sales by Manufacturers (2011-2016)
Table Japan High Potency Active Pharmaceutical Ingredient Market Share by Manufacturers (2011-2016)
Table Japan High Potency Active Pharmaceutical Ingredient Sales by Type (2011-2016)
Table Japan High Potency Active Pharmaceutical Ingredient Market Share by Type (2011-2016)
Table Japan High Potency Active Pharmaceutical Ingredient Sales by Application (2011-2016)
Table Japan High Potency Active Pharmaceutical Ingredient Market Share by Application (2011-2016)
Table Alkermes Basic Information List
Table Alkermes High Potency Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Alkermes High Potency Active Pharmaceutical Ingredient Global Market Share (2011-2016)
Table Cambex Basic Information List
Table Cambex High Potency Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Cambex High Potency Active Pharmaceutical Ingredient Global Market Share (2011-2016)
Table Dr. Reddy’s Labotatories Basic Information List
Table Dr. Reddy’s Labotatories High Potency Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Dr. Reddy’s Labotatories High Potency Active Pharmaceutical Ingredient Global Market Share (2011-2016)
Table Lonza Group Basic Information List
Table Lonza Group High Potency Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Lonza Group High Potency Active Pharmaceutical Ingredient Global Market Share (2011-2016)
Table Novasep Basic Information List
Table Novasep High Potency Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Novasep High Potency Active Pharmaceutical Ingredient Global Market Share (2011-2016)
Table Sandoz Basic Information List
Table Sandoz High Potency Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Sandoz High Potency Active Pharmaceutical Ingredient Global Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of High Potency Active Pharmaceutical Ingredient
Figure Manufacturing Process Analysis of High Potency Active Pharmaceutical Ingredient
Figure High Potency Active Pharmaceutical Ingredient Industrial Chain Analysis
Table Raw Materials Sources of High Potency Active Pharmaceutical Ingredient Major Manufacturers in 2015
Table Major Buyers of High Potency Active Pharmaceutical Ingredient
Table Distributors/Traders List
Figure Global High Potency Active Pharmaceutical Ingredient Sales and Growth Rate Forecast (2016-2021)
Figure Global High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate Forecast (2016-2021)
Table Global High Potency Active Pharmaceutical Ingredient Sales Forecast by Regions (2016-2021)
Table Global High Potency Active Pharmaceutical Ingredient Sales Forecast by Type (2016-2021)
Table Global High Potency Active Pharmaceutical Ingredient Sales Forecast by Application (2016-2021)